$1500 | Single User
$2000 | Multi User

Global Liquid Biopsy Market Outlook to 2020
[Lowest Price Guaranteed: $1,500]

Published by RNCOS: 01 Feb 2016 | 24760 | In Stock
Related Topics: Immunology , Infectious Disease

Introduction

The recent discovery of liquid biopsy technology and its wide applicability have sparked off a lot of interest among researchers along with the commercial players. Owing to the same, there are numerous clinical trials being organized all over the world in order to assess the potential of liquid biopsy in various fields such as cancer, prenatal screening and organ transplant monitoring.

As indicated by the new estimation carried out in our most recent study, the global liquid biopsy industry is expected to cross US$ 1 Billion mark by the end of 2020, as new products, especially those in the advanced stage of clinical studies or with pending approvals, might enter the market to support the development.

According to RNCOS’ new research report “Global Liquid Biopsy Market Outlook to 2020”, a major focus has been on the development of innovative products based on different technologies and different sample types. In this context, the study provides present and future outlooks for the two broad categories of liquid biopsy market; by technology and by sample type. The former comprises of the three marker categories that dominate liquid biopsy today: Circulating Tumor Cells (CTCs), circulating tumor DNA (ctDNA), and extracellular vesicles (or exosomes). On the other hand, the latter includes the two major bodily fluid samples: blood and urine. According to report, blood is the most widely used sample type, and is expected to remain the largest market based on sample type in the coming years as well. The report also includes a detailed pipeline analysis of upcoming liquid biopsy products along with the sample type utilized.

Most of the current research is focused on utilizing liquid biopsy for diagnostic purposes, such as response evaluation, expression profiling, tumor diagnosis and treatment monitoring in a blood test. The flexible design of the liquid biopsy platform supports a variety of research areas, including Stem cell research, Oncology, Infectious Disease, Immunology, Endothelial Cells, and Fetal Cells.

The market has been divided into four major geographic regions - North America, Europe, Asia and Rest of the World. North America is the largest market for the liquid biopsy. This high share is attributed to relative high adoption of liquid biopsy, coupled with launch of new and advanced products in the market. The Asian market is poised to witness the highest growth owing to increasing focus of players in this region.

RNCOS, in its report, further covers how major trends and drivers, mainly therapy monitoring, increasing use of Circulating tumor DNA for cancer screening, growing interest of venture capital firms, etc. will propel the industry’s growth. An analysis has also been done of a few factors limiting the growth of the industry.

After an exhaustive study of the industry, RNCOS has laid out the primary market players which are engaged in providing liquid biopsy based tools and services. These players are working over a vast variety of products, such as blood based tests, urine based tests, assays and instruments for sample extraction, amplification and purification, and constantly upgrading their portfolio to keep up with the latest developments in the field. Some of these players include NeoGenomics, Trovagene, Guardant Health, Biocept, Biocartis, and Pathway Genomics.

Overall, even though the market is in its nascent stage at the moment, it is expanding at an almost exponential rate. With new players entering the market, increase in the number of collaborations and strong support from research institutes, the liquid biopsy market is bound to witness rampant diversification and growth in the coming years.

Table of Contents
for Global Liquid Biopsy Market Outlook to 2020

  • 1. Analyst View

    2. Research Methodology

    3. Liquid Biopsy - An Introduction

    4. Market Dynamics

    4.1 Market Drivers

    4.1.1 High Prevalence of Cancer

    4.1.2 Technological Advancements in Personalized Therapies

    4.1.3 Increasing Demand for Minimally-Invasive Biopsy Techniques

    4.1.4 Lower Cost

    4.1.5 Growing Interest of Venture Capital Firms

    4.2 Market Restraints

    4.2.1 A Less-Defined Regulatory Environment

    4.2.2 Comparatively Low Concentration of Molecular Biomarkers in Body Fluids

    4.2.3 Need for Proper Handling and Storage of the Samples

    4.3 Market Opportunities

    4.3.1 Exosomes Offer Great Advantages as Source Materials

    4.3.2 Next Generation Sequencing Offers Significant Opportunity

    4.3.3 Prenatal Screening & Organ Transplantation: Upcoming Applications

    4.3.4 Growing Researches on Cerebrospinal Fluid as Sample Source

    4.4 Industry Trends

    4.4.1 Strong Preference for ctDNA Among Various Biomarkers

    4.4.2 Blood: The Most Widely Used Sample

    5. Global Liquid Biopsy Market Outlook to 2020

    6. Global Liquid Biopsy Market Size by Technology

    6.1 Circulating Tumor Cells (CTCs)

    6.2 Circulating Tumor DNA/Cell free DNA (ctDNA/cfDNA)

    6.3 Exosomes

    7. Global Liquid Biopsy Market Size by Sample Type

    7.1 Blood

    7.2 Urine

    8. Global Liquid Biopsy Market Size by Geography

    8.1 North America

    8.2 Europe

    8.3 Asia

    8.4 Rest of the World (RoW)

    9. Pipeline Analysis

    10. Key Player Analysis

    10.1 Personal Genome Diagnostics

    10.2 Guardant Health, Inc.

    10.3 Pathway Genomics

    10.4 NeoGenomics, Inc.

    10.5 RainDance Technology

    10.6 Trovagene, Inc.

    10.7 Circulogene Theranostics

    10.8 Biocartis

    10.9 Cynvenio Biosystems, Inc.

    10.10 Biocept, Inc.

    10.11 ANGLE plc

    10.12 MDxHealth

    10.13 Clearbridge BioMedics Pte Ltd

    10.14 Exosome Diagnostics, Inc.

    List of Figures:

    Figure 5-1: Global - Liquid Biopsy Market (Million US$), 2015 & 2020

    Figure 6-1: Global - Liquid Biopsy Market by Technology (%), 2015

    Figure 6-2: Global - Liquid Biopsy Market for CTCs (Million US$), 2015 & 2020

    Figure 6-3: Global - Liquid Biopsy Market for ctDNA (Million US$), 2015 & 2020

    Figure 6-4: Global - Liquid Biopsy Market for Exosomes (Million US$), 2015 & 2020

    Figure 7-1: Global - Liquid Biopsy Market by Sample Type (%), 2015

    Figure 7-2: Global - Blood Based Liquid Biopsy Market (Million US$), 2015 & 2020

    Figure 7-3: Global - Urine Based Liquid Biopsy Market (Million US$), 2015 &2020

    Figure 8-1: Global - Liquid Biopsy Market by Geography (%), 2015

    Figure 8-2: North America - Liquid Biopsy Market (Million US$), 2015 & 2020

    Figure 8-3: Europe - Liquid Biopsy Market (Million US$), 2015 & 2020

    Figure 8-4: Asia - Liquid Biopsy Market (Million US$), 2015 & 2020

    List of Tables:

    Table 4-1: Global - Cancer Incidence by Region (Million), 2020

    Table 4-2: Comparison of the Analysis Capability of CTC's, cfDNA and Exosomes

    Table 8-1: North America - Cancer Incidences by Type ('000), 2015 & 2020

    Table 8-2: Europe - Cancer Incidences by Type ('000), 2015 & 2020

    Table 8-3: Asia - Cancer Incidences by Type ('000), 2015 & 2020

    Table 9-1: Pipeline Analysis for Liquid Biopsy

    Table 10-1: Personal Genome Diagnostics - Liquid Biopsy Associated Product Line

    Table 10-2: Guardant Health - Liquid Biopsy Associated Product Line

    Table 10-3: Pathway Genomics - Liquid Biopsy Associated Product Line

    Table 10-4: NeoGenomics, Inc. - Key Financials (Million US$), 2012-2014

    Table 10-5: NeoGenomics - Liquid Biopsy Associated Product Line

    Table 10-6: RainDance Technologies - Key Financials (Million US$), 2012-2014

    Table 10-7: RainDance Technology - Liquid Biopsy Associated Product Line

    Table 10-8: Trovagene - Key Financials (Million US$), 2013-2015

    Table 10-9: Trovagene - Liquid Biopsy Associated Product Line

    Table 10-10: Circulogene Theranostics - Liquid Biopsy Associated Product Line

    Table 10-11: Biocartis Group NV - Key Financials (Million US$), 2012-2014

    Table 10-12: Biocartis - Liquid Biopsy Associated Product Line

    Table 10-13: Cynvenio Biosystems, Inc. - Liquid Biopsy Associated Product Line

    Table 10-14: Biocept, Inc. - Key Financials (Million US$), 2012-2014

    Table 10-15: Biocept, Inc. - Liquid Biopsy Associated Product Line

    Table 10-16: ANGLE plc - Key Financials (Million US$), 2013-2015

    Table 10-17: ANGLE plc - Liquid Biopsy Associated Product Line

    Table 10-18: MDxHealth - Key Financials (Million US$), 2012-2014

    Table 10-19: MDxHealth - Liquid Biopsy Associated Product Line

    Table 10-20: Clearbridge BioMedics Pte Ltd - Liquid Biopsy Associated Product Line

    Table 10-21: Exosome Diagnostics, Inc. - Liquid Biopsy Associated Product Line

Additional Details

Publisher

RNCOS

Publisher Information

RNCOS is a Business Consulting Service firm providing multiple services to companies wishing to engage in any business expansion.



We uniquely position our self as a "one-stop-shop" offering a broad spectrum of Management Consulting and Business facilitation services including but not limited to Financial & Business Assessment, Market Entry / Expansion Strategies, Market and Industry Research, Identification & Selection of Business Partners, Feasibility and Facility Location Studies etc.



Since our inception in 2002, we have gained industry experience and expertise in offering research solutions to distinguished clientele' across multi geographies and industry verticals. We help our clients in achieving sustainable performance and better growth prospects by weeding out their obsolete business process with well laid strategies by working in close co-ordination with them.



Be it market entry, product testing, competition assessment, customer satisfaction study, pricing analysis or any other requirement, RNCOS team acts proactively to fit in the best possible solution for our valued clients. We believe in multi-level client interaction and complete transparency from the project commencement till effective implementation, thus ensuring total customer satisfaction.

Reference

24760 |

Number of Pages

90

Report Format

PDF

RNCOS Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Fillings & Toppings Market by Type (Fondants, Creams, Pastes & Variegates, Fruits & Nuts, Sprinkles), Application (Bakery, Confectionery), Flavor (Fruit, Chocolate), Raw Material (Sweeteners, Cocoa), and Form (Solid, Liquid) - Global Forecasts to 2022
“Fillings & toppings market projected to grow at a CAGR of 5.63%”The fillings & toppings market is p...
24 Nov 2016 by MarketsandMarkets USD $5,650 More Info
Fermented Ingredients Market by Type (Amino Acids, Organic Acids, Biogas, Polymers, Vitamins, Industrial Enzymes), Application (Food & Beverages, Feed, Pharmaceuticals, Paper), Form (Dry, and Liquid), and Region - Global Forecast to 2022
“Fermented ingredients market projected to grow at a CAGR of 9.0% from 2017 to 2022”The fermented in...
21 Nov 2016 by MarketsandMarkets USD $5,650 More Info
3D Printing Ceramics Market by Type (Glass, Fused Silica, Quartz), Form (Filament, Powder, & Liquid), End User (Aerospace & Defense, Automotive, Consumer Goods & Electronics, Manufacturing & Construction, Healthcare) - Global Forecast to 2021
“End-user segment is one of the driving factors, as 3D printing ceramics are widely used in high-the...
05 Sep 2016 by MarketsandMarkets USD $5,650 More Info
Extrusion Coating Market by Material Type (LDPE, EVA, Polypropylene, Polyethylene Terephthalate), Substrate (Paperboard, Films, Aluminum Foil, Polymer), Application (Liquid Packaging, Flexible Packaging, Commercial Packaging) - Global Forecast to 2021
“High demand from food & beverages packaging sector driving the extrusion coating market” The market...
05 Sep 2016 by MarketsandMarkets USD $5,650 More Info
Liquid Fertilizers Market by Type (Nitrogen, Phosphorus, Potash, Micronutrients), Mode of Application (Soil, Foliar & Fertigation), Form (Organic & Synthetic), Crop Type, and Region - Global Forecast to 2021
“Liquid fertilizers market is projected to grow at a CAGR of 3.1%.”The liquid fertilizers market is ...
01 Sep 2016 by MarketsandMarkets USD $5,650 More Info
Liquid Milk Industry Overview in China, 2011-2020
DescriptionLiquid milk refers to packed dairy products in liquid form. According to definition of In...
25 Jul 2016 by CRI USD $1,800 More Info
Disposable Tips For Automated Liquid Handlers Trends 2016
HTStec's Disposable Tips For Automated Liquid Handlers Trends 2016 report was published on 23 June 2...
23 Jun 2016 by HTStec USD $2,000 More Info
Sample Preparation Market by Product (Instruments (Workstations, Liquid Handling Systems), Consumables (Kits, Filters)), Application (Genomics, Proteomics), End Users (Pharmaceutical and Biotechnology, Food and Beverage) - Global Forecast to 2021
The sample preparation market is poised to reach USD 7,203.2 million by 2021 from USD 5,512.2 in 201...
14 Jun 2016 by MarketsandMarkets USD $5,650 More Info
Advanced Liquid Logic, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
SummaryMarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments r...
15 Apr 2016 by Marketline USD $350 More Info
Pharmaceutical Packaging Equipment Market by Package Type (Blister, Strip, Bottle, Tube, Aseptic Packaging, Wrapping, Labeling & Serialization), by Product Type (Tablet, Powder, Cream, Syrup, Aseptic Liquid, Aerosol) - Global Forecast to 2020
The global pharmaceutical packaging equipment market is expected to grow at a CAGR of 6.9% during th...
10 Feb 2016 by MarketsandMarkets USD $4,650 More Info

This report is published by RNCOS

RNCOS is a Business Consulting Service firm providing multiple services to companies wishing to engage in any business expansion.

We uniquely position our self as a "one-stop-shop" offering a broad spectrum of Management Consulting and Business facilitation services including but not limited to Financial & Business Assessment, Market Entry / Expansion Strategies, Market and Industry Research, Identification & Selection of Business Partners, Feasibility and Facility Location Studies etc.

Since our inception in 2002, we have gained industry experience and expertise in offering research solutions to distinguished clientele' across multi geographies and industry verticals. We help our clients in achieving sustainable performance and better growth prospects by weeding out their obsolete business process with well laid strategies by working in close co-ordination with them.

Be it market entry, product testing, competition assessment, customer satisfaction study, pricing analysis or any other requirement, RNCOS team acts proactively to fit in the best possible solution for our valued clients. We believe in multi-level client interaction and complete transparency from the project commencement till effective implementation, thus ensuring total customer satisfaction.

Download Free Report Summary PDF

Global Liquid Biopsy Market Outlook to 2020 | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...